Activin a as a mediator of nk-dendritic cell functional interactions

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 1241-1248

  Seeger, Pascal ^a   Bosisio, Daniela ^a   Parolini, Silvia ^a   Badolato, Raffaele ^a   Gismondi, Angela ^b   Santoni, Angela ^b   Sozzani, Silvano ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CD1C ANTIGEN; FOLLISTATIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL CONTACT; CELL INTERACTION; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL;

ACTIVINS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; COCULTURE TECHNIQUES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DOGS; FEEDBACK, PHYSIOLOGICAL; FOLLISTATIN; HERMANSKI-PUDLAK SYNDROME; HUMANS; IMMUNOGLOBULINS; INTERLEUKIN-15; INTERLEUKIN-8; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MONOCYTES; RECEPTORS, NATURAL KILLER CELL; UP-REGULATION;

EID: 84893360652     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301487     Document Type: Article

References (47)

1. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5: 405-411.
2. Lui, G., P. Carrega, and G. Ferlazzo. 2006. Principles of NK Cell/DC crosstalk: the importance of cell dialogue for a protective immune response. Transfus. Med. Hemother. 33: 50-57.
3. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contactdependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335-341.
4. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333.
5. Cooper, M. A., T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri. 2004. NK cell and DC interactions. Trends Immunol. 25: 47-52.
6. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Naturalkiller cells and dendritic cells: "l'union fait la force". Blood 106: 2252-2258.
7. Moretta, A. 2002. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2: 957-964.
8. Vitale, M., M. Della Chiesa, S. Carlomagno, C. Romagnani, A. Thiel, L. Moretta, and A. Moretta. 2004. The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferongamma production upon interaction with dendritic cells. Eur. J. Immunol. 34: 1715-1722.
9. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195: 343-351.
10. Gerosa, F., A. Gobbi, P. Zorzi, S. Burg, F. Briere, G. Carra, and G. Trinchieri. 2005. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 174: 727-734.
11. Ferlazzo, G., M. Pack, D. Thomas, C. Paludan, D. Schmid, T. Strowig, G. Bougras, W. A. Muller, L. Moretta, and C. Munz. 2004. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 101: 16606-16611.
12. Borg, C., A. Jalil, D. Laderach, K. Maruyama, H. Wakasugi, S. Charrier, B. Ryffel, A. Cambi, C. Figdor, W. Vainchenker, et al. 2004. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104: 3267-3275.
13. Marcenaro, E., S. Carlomagno, S. Pesce, A. Moretta, and S. Sivori. 2012. NK/DC crosstalk in anti-viral response. Adv. Exp. Med. Biol. 946: 295-308.
14. Degli-Esposti, M. A., and M. J. Smyth. 2005. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5: 112-124.
15. Koka, R., P. Burkett, M. Chien, S. Chai, D. L. Boone, and A. Ma. 2004. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J. Immunol. 173: 3594-3598.
16. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Arico, L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571.
17. Yu, Y., M. Hagihara, K. Ando, B. Gansuvd, H. Matsuzawa, T. Tsuchiya, Y. Ueda, H. Inoue, T. Hotta, and S. Kato. 2001. Enhancement of human cord blood CD34 + cell-derived NK cell cytotoxicity by dendritic cells. J. Immunol. 166: 1590-1600.
18. Semino, C., G. Angelini, A. Poggi, and A. Rubartelli. 2005. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106: 609-616.
19. Ling, N., S. Y. Ying, N. Ueno, S. Shimasaki, F. Esch, M. Hotta, and R. Guillemin. 1986. A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochem. Biophys. Res. Commun. 138: 1129-1137.
20. Phillips, D. J., D. M. de Kretser, and M. P. Hedger. 2009. Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev. 20: 153-164.
21. Sierra-Filardi, E., A. Puig-Kroger, F. J. Blanco, C. Nieto, R. Bragado, M. I. Palomero, C. Bernabéu, M. A. Vega, and A. L. Corbí. 2011. Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117: 5092-5101.
22. Hedger, M. P., W. R. Winnall, D. J. Phillips, and D. M. de Kretser. 2011. The regulation and functions of activin and follistatin in inflammation and immunity. Vitam. Horm. 85: 255-297.
23. Sozzani, S., and T. Musso. 2011. The yin and yang of Activin A. Blood 117: 5013-5015.
24. Robson, N. C., D. J. Phillips, T. McAlpine, A. Shin, S. Svobodova, T. Toy, V. Pillay, N. Kirkpatrick, D. Zanker, K. Wilson, et al. 2008. Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111: 2733-2743.
25. Robson, N. C., H. Wei, T. McAlpine, N. Kirkpatrick, J. Cebon, and E. Maraskovsky. 2009. Activin-A attenuates several human natural killer cell functions. Blood 113: 3218-3225.
26. Vulcano, M., S. Struyf, P. Scapini, M. Cassatella, S. Bernasconi, R. Bonecchi, A. Calleri, G. Penna, L. Adorini, W. Luini, et al. 2003. Unique regulation of CCL18 production by maturing dendritic cells. J. Immunol. 170: 3843-3849.
27. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 16: 137-161.
28. Li, M. O., and R. A. Flavell. 2008. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28: 468-476.
29. Scutera, S., E. Riboldi, R. Daniele, A. R. Elia, T. Fraone, C. Castagnoli, M. Giovarelli, T. Musso, and S. Sozzani. 2008. Production and function of activin A in human dendritic cells. Eur. Cytokine Netw. 19: 60-68.
30. Fontana, S., S. Parolini, W. Vermi, S. Booth, F. Gallo, M. Donini, M. Benassi, F. Gentili, D. Ferrari, L. D. Notarangelo, et al. 2006. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 107: 4857-4864.
31. Phillips, D. J., and D. M. de Kretser. 1998. Follistatin: a multifunctional regulatory protein. Front. Neuroendocrinol. 19: 287-322.
32. Goldszmid, R. S., and G. Trinchieri. 2012. The price of immunity. Nat. Immunol. 13: 932-938.
33. Miyake, Y., and S. Yamasaki. 2012. Sensing necrotic cells. Adv. Exp. Med. Biol. 738: 144-152.
34. Semino, C., J. Ceccarelli, L. V. Lotti, M. R. Torrisi, G. Angelini, and A. Rubartelli. 2007. The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J. Leukoc. Biol. 81: 92-99.
35. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
36. Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191: 423-434.
37. Tesniere, A., L. Apetoh, F. Ghiringhelli, N. Joza, T. Panaretakis, O. Kepp, F. Schlemmer, L. Zitvogel, and G. Kroemer. 2008. Immunogenic cancer cell death: a key-lock paradigm. Curr. Opin. Immunol. 20: 504-511.
38. Antsiferova, M., and S. Werner. 2012. The bright and the dark sides of activin in wound healing and cancer. J. Cell Sci. 125: 3929-3937.
39. Ogawa, K., and M. Funaba. 2011. Activin in humoral immune responses. Vitam. Horm. 85: 235-253.
40. Semitekolou, M., T. Alissafi, M. Aggelakopoulou, E. Kourepini, H. H. Kariyawasam, A. B. Kay, D. S. Robinson, C. M. Lloyd, V. Panoutsakopoulou, and G. Xanthou. 2009. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J. Exp. Med. 206: 1769-1785.
41. Agaugué, S., E. Marcenaro, B. Ferranti, L. Moretta, and A. Moretta. 2008. Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 112: 1776-1783.
42. Jonuleit, H., E. Schmitt, G. Schuler, J. Knop, and A. H. Enk. 2000. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
43. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5: 1260-1265.
44. Musso, T., S. Scutera, W. Vermi, R. Daniele, M. Fornaro, C. Castagnoli, D. Alotto, M. Ravanini, I. Cambieri, L. Salogni, et al. 2008. Activin A induces Langerhans cell differentiation in vitro and in human skin explants. PLoS ONE 3: e3271.
45. Shegarfi, H., F. Naddafi, and A. Mirshafiey. 2012. Natural killer cells and their role in rheumatoid arthritis: friend or foe? ScientificWorldJournal 2012: 491974.
46. Parolini, S., A. Santoro, E. Marcenaro, W. Luini, L. Massardi, F. Facchetti, D. Communi, M. Parmentier, A. Majorana, M. Sironi, et al. 2007. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109: 3625-3632.
47. Sarkar, S., and D. A. Fox. 2005. Dendritic cells in rheumatoid arthritis. Front. Biosci. 10: 656-665.